Back to
Woodline Partners LP
JAZZ16 quarters
Position history for
Woodline Partners LP's holdings in Jazz Pharmaceuticals Public Limited Company
Yes. Woodline Partners holds 150,083 shares of JAZZ (Jazz Pharmaceuticals Public), worth $36.2M, as of its Q2 2026 13F filing. It opened the position in Q2 2026. JAZZ is 0.1% of Woodline Partners' reported 13F portfolio.
Current Value
$36.2M
Current Shares
150,083
Total Value Change
+$24.7M
Total Shares Change
+46,279
Quarter-by-Quarter History
Other major holders of JAZZ: BlackRock, Inc., FMR LLC, VANGUARD GROUP INC